GLP-1s Aren't Slowing Down: The Wholesale Case for Tirzepatide & Retatrutide

The GLP-1 wave isn't a moment — it's a category. Tirzepatide and retatrutide have become two of the most-discussed research peptides on the planet, with metabolic-research communities tracking dosage protocols, titration schedules, and side-effect mitigation in real time. The publicly available data on metabolic markers, appetite regulation and body composition continues to expand, and so does demand.

From a wholesale standpoint, the math is simple. A single 10-vial tirzepatide kit covers months of a typical research protocol. Researchers and resellers who stock by the kit aren't paying retail markups — they're operating at the same per-vial cost a small clinic would pay through a compounding supplier, with the added benefit of COA documentation on every batch.

Retatrutide — the triple agonist — is the rising star. Early research data shows it acting on three receptor pathways at once, and the early adopters in research circles are already running structured logs. For resellers, that means a window: the brands that stock retatrutide today, with proper documentation, build credibility before the broader market catches up.

Both peptides ship in our 10-vial wholesale kits at true bulk pricing. Free worldwide tracked delivery, COA on every batch, crypto and Solana Pay checkout — no merchant account, no chargebacks, no surprises.